北大医药股票的历史最低价股票

Hi,这是的腾讯微博,别吝惜你的关注,赶紧登录,和TA互动吧!
正在加载...
Copyright & 1998 - 2016 Tencent. All Rights Reserved[{"date":"","value":"0.60","vol":"2.33"},{"date":"","value":"2.23","vol":"13.10"},{"date":"","value":"-18.26","vol":"9.59"},{"date":"","value":"-11.63","vol":"6.38"},{"date":"","value":"-8.08","vol":"2.46"}]
净资产收益率(%)
该指标值越高,盈利能力越强,行业排名越靠前。
销售毛利率
[{"date":"","value":"19.38","vol":"46.34"},{"date":"","value":"12.46","vol":"44.07"},{"date":"","value":"10.79","vol":"47.23"},{"date":"","value":"10.69","vol":"44.10"},{"date":"","value":"5.61","vol":"41.51"}]
销售毛利率(%)
该指标值越高,盈利能力越强,行业排名越靠前。
成长能力:较强,高于行业平均,建议加强关注,两项指标的行业排名分别为 60/160 , 7/160。
营业收入同比增长率
[{"date":"","value":"-11.84","vol":"17.49"},{"date":"","value":"-11.26","vol":"40.34"},{"date":"","value":"-10.58","vol":"8.82"},{"date":"","value":"-20.99","vol":"11.14"},{"date":"","value":"-13.73","vol":"11.98"}]
营业收入同比增长率(%)
该指标值越高,成长能力越强,行业排名越靠前。
净利润同比增长率
[{"date":"","value":"107.85","vol":"32.37"},{"date":"","value":"192.34","vol":"86.60"},{"date":"","value":"-431.50","vol":"92.77"},{"date":"","value":"-401.81","vol":"946.24"},{"date":"","value":"-494.65","vol":"77.79"}]
净利润同比增长率(%)
该指标值越高,成长能力越强,行业排名越靠前。
营运能力:较强,高于行业平均,建议加强关注,两项指标的行业排名分别为 32/160 , 8/160。
总资产周转率
[{"date":"","value":"0.13","vol":"0.14"},{"date":"","value":"0.52","vol":"0.66"},{"date":"","value":"0.36","vol":"0.46"},{"date":"","value":"0.21","vol":"0.34"},{"date":"","value":"0.10","vol":"0.15"}]
总资产周转率(次)
该指标值越高,营运能力越强,行业排名越靠前。
存货增长率
[{"date":"","value":"1.42","vol":"0.82"},{"date":"","value":"4.38","vol":"3.97"},{"date":"","value":"2.45","vol":"2.58"},{"date":"","value":"1.38","vol":"2.14"},{"date":"","value":"0.67","vol":"0.77"}]
存货增长率(次)
该指标值越高,营运能力越强,行业排名越靠前。
现金流能力:数据暂时不全,请后续关注
经营活动产生的现金流量净额/营业收入
[{"date":"","value":"-39.39","vol":"4.42"},{"date":"","value":"105.71","vol":"10.05"},{"date":"","value":"-17.42","vol":"12.75"},{"date":"","value":"2.21","vol":"11.65"},{"date":"","value":"22.54","vol":"7.20"}]
现金流量净额/营业收入
该指标值越高,现金流能力越强,行业排名越靠前。
资本支出/折旧和摊销
[{"date":"","value":"","vol":"0.00"},{"date":"","value":"1.23","vol":"3.11"},{"date":"","value":"","vol":"0.74"},{"date":"","value":"0.71","vol":"2.59"},{"date":"","value":"","vol":"0.22"}]
资本支出/折旧和摊销
该指标值越低,现金流能力越强,行业排名越靠前。
短期偿债能力:很强,位居行业前列,建议强烈关注,两项指标的行业排名分别为 20/160 , 23/160。
[{"date":"","value":"1.51","vol":"3.06"},{"date":"","value":"1.44","vol":"4.91"},{"date":"","value":"0.73","vol":"3.97"},{"date":"","value":"0.73","vol":"5.06"},{"date":"","value":"0.75","vol":"3.59"}]
该指标值越接近2,短期偿债能力越强,行业排名越靠前。
[{"date":"","value":"1.24","vol":"1.97"},{"date":"","value":"1.29","vol":"3.17"},{"date":"","value":"0.50","vol":"2.79"},{"date":"","value":"0.46","vol":"3.70"},{"date":"","value":"0.48","vol":"2.10"}]
该指标值越接近1,短期偿债能力越强,行业排名越靠前。
长期偿债能力:较强,高于行业平均,建议加强关注,两项指标的行业排名分别为 20/160 , 8/160。
资产负债率
[{"date":"","value":"61.08","vol":"34.55"},{"date":"","value":"63.81","vol":"35.99"},{"date":"","value":"78.91","vol":"35.45"},{"date":"","value":"76.74","vol":"35.64"},{"date":"","value":"77.16","vol":"36.54"}]
资产负债率(%)
该指标值越接近50%,长期偿债能力越强,行业排名越靠前。
[{"date":"","value":"1.57","vol":"0.73"},{"date":"","value":"1.76","vol":"0.82"},{"date":"","value":"3.78","vol":"0.82"},{"date":"","value":"3.35","vol":"0.82"},{"date":"","value":"3.44","vol":"0.90"}]
产权比率(%)
该指标值越高,长期偿债能力越强,行业排名越靠前。
最近60个交易日,机构对该股票关注较少,无任何评级。
机构预测该股2016年每股收益相比前一年增长200.00%,长期投资价值高。
[{"date":"2012","yellowRectValue":"0.76","blueLineValue":"0.13","type":""},{"date":"2013","yellowRectValue":"0.78","blueLineValue":"0.13","type":""},{"date":"2014","yellowRectValue":"-0.27","blueLineValue":"-0.05","type":""},{"date":"2015","yellowRectValue":"0.25","blueLineValue":"0.04","type":""},{"date":"2016","yellowRectValue":"0.72","blueLineValue":"0.12","type":"YC"}]北大医药遭证监会立案调查 股价跌近4%_凤凰财经
北大医药遭证监会立案调查 股价跌近4%
用微信扫描二维码分享至好友和朋友圈
凤凰财经讯周五,北大医药受利空消息打压,股价大跌。截至发稿时,报16.80元,跌幅3.72%。 据中国证券报报道,北大医药11月20日晚公告,北大医药于日收到中国证监会《调查通知书》,因公司涉嫌违反证券法律法规,根据《证券法》的有关规定,决定对公司进行立案调查。 北大医药表示,调查期间,公司将积极配合相关监管机构的调查工作,并将根据调查情况及时履行信息披露义务。目前公司生产经营状况正常。公司股票将于21日复牌交易。 根据公告,北大资源集团回复问询时表示,&代持关系为被迫实施的安排&,&被迫代持中不存在任何个人或企业非法牟利&,&不构成内幕交易行为&。 不过,政泉控股方面15日发出公开声明邀约方正集团CEO李友公开对质,并称,&我司已就李友、魏新、余丽、李国军等方正集团&四人帮&内幕交易、侵吞国有资产、制造多个虚假身份证件等多个违法犯罪行为,分别向证监机关、纪律检查机关及公安司法机关进行举报。& 方正集团则通过上市公司公告称:&我公司及我公司董事、监事和高级管理人员均未委托政泉控股代持北大医药股票,我公司也未委托北大资源集团控股有限公司代持北大医药股票。我公司及我公司董事、监事、高级管理人员绝无政泉控股质疑的内幕交易行为。& 北大资源集团称&代持关系为被迫实施的安排&。据其介绍,政泉控股依法取得受让方资格后,表示其目前资金紧张,请求方正集团协助短期借款,支付股权转让保证金。鉴于当时股份转让已经获得主管机关审核批准,再三权衡利弊,北大资源集团协调资金,支持政泉控股完成了股份受让。期间,北大资源集团担心约定不明的情形会导致国有资产面临风险,经与政泉控股协商,不得已与其达成所谓代持协议。 北大资源集团还称,除被政泉控股扣留的部分外,减持收益已全部回到北大资源集团账上。并强调,被迫代持中不存在任何个人或企业非法牟利,同时从主观故意、信息获取、信息形成时间以及行为主体各方面均不构成内幕交易行为。 北大医药同日还公告称,公司于11月20日收到股东北大医疗的通知,北大医疗计划在未来12个月内增持不超过公司现已发行总股本2%的股份(公司重大资产重组实施完成前)。
[责任编辑:zhanghl]
用微信扫描二维码分享至好友和朋友圈
【独家稿件声明】凡注明“凤凰财经”来源之作品(文字、图片、图表或音视频),未经授权,任何媒体和个人不得全部或者部分转载。如需转载,请与凤凰网财经频道(010-)联系;经许可后转载务必请注明出处,违者本网将依法追究。
预期年化利率
凤凰点评:凤凰集团旗下公司,轻松理财。
近一年收益
凤凰点评:业绩长期领先,投资尖端行业。
近3个月收益
凤凰点评:进可攻退可守,抗跌性能尤佳。
同系近一年收益
凤凰点评:震荡市场首选,防御性能极佳且收益喜人,老总私人追加百万。
04/13 08:36
04/13 08:36
04/13 08:38
04/13 08:37
04/13 08:37
04/13 09:27
04/13 09:27
04/13 09:27
04/13 09:27
04/13 09:28
12/03 09:23
12/03 09:07
12/03 08:12
12/03 08:12
12/03 09:26
04/13 09:04
04/13 09:04
04/13 09:04
04/13 09:04
04/13 09:04
04/13 00:38
04/13 00:38
04/13 00:38
04/13 00:38
04/13 00:38
凤凰财经官方微信
播放数:5808920
播放数:1395600
播放数:1139257
播放数:5808920
48小时点击排行

我要回帖

更多关于 北大医药股票行情 的文章

 

随机推荐